Lin Gang, Sun Xiao-Jiang, Han Qian-Bo, Wang Zhun, Xu Ya-Ping, Gu Jia-Lei, Wu Wei, Zhang G U, Hu Jin-Lin, Sun Wen-Yong, Mao Wei-Min
First Clinical Medical School, Wenzhou Medical University, Wenzhou, Zhejiang 325035, P.R. China ; Department of Radiation Oncology, Zhejiang Cancer Hospital, Hangzhou, Zhejiang 310022, P.R. China.
Department of Radiation Oncology, Zhejiang Cancer Hospital, Hangzhou, Zhejiang 310022, P.R. China.
Oncol Lett. 2015 Aug;10(2):901-906. doi: 10.3892/ol.2015.3277. Epub 2015 May 27.
Alterations of the epidermal growth factor receptor (EGFR), including overexpression or gene mutations, contribute to the malignant transformation of human epithelial cells. The aim of this study was to assess EGFR overexpression or gene amplification in esophageal squamous cell carcinoma (ESCC) tissue samples and investigate their correlations with biological behaviors. Tissue specimens from 56 patients with surgically resected ESCC were obtained for immunohistochemical analysis of EGFR expression and fluorescence hybridization analysis of amplification. The data were statistically analyzed to determine the associations with patient clinicopathological and survival data. EGFR was overexpressed in 30 of the 56 (53.6%) ESCC samples and was associated with poor tumor differentiation (P=0.047). amplification was detected in 13 cases (23.2%) and was associated with advanced pathological stage (P=0.042) and tumor lymph node metastasis (P=0.002). The univariate analysis identified no association between EGFR overexpression and the overall survival (OS) of the patients. By contrast, amplification predicted ESCC prognosis (P=0.031), while the multivariate analysis revealed a marginal statistical significance for the association between amplification and OS (P=0.056). EGFR overexpression and increased copy number were common events in ESCC and contributed to malignant biological behaviors, including tumor dedifferentiation and lymph node metastasis. amplification may therefore be useful in predicting OS in patients with ESCC.
表皮生长因子受体(EGFR)的改变,包括过表达或基因突变,促成了人类上皮细胞的恶性转化。本研究的目的是评估食管鳞状细胞癌(ESCC)组织样本中EGFR的过表达或基因扩增情况,并研究它们与生物学行为的相关性。获取了56例接受手术切除的ESCC患者的组织标本,用于EGFR表达的免疫组织化学分析和扩增的荧光杂交分析。对数据进行统计学分析,以确定与患者临床病理和生存数据的关联。56例ESCC样本中有30例(53.6%)EGFR过表达,且与肿瘤低分化相关(P = 0.047)。13例(23.2%)检测到扩增,且与病理分期晚(P = 0.042)和肿瘤淋巴结转移(P = 0.002)相关。单因素分析未发现EGFR过表达与患者总生存期(OS)之间存在关联。相比之下,扩增可预测ESCC预后(P = 0.031),而多因素分析显示扩增与OS之间的关联具有边缘统计学意义(P = 0.056)。EGFR过表达和拷贝数增加是ESCC中的常见事件,并促成了恶性生物学行为,包括肿瘤去分化和淋巴结转移。因此,扩增可能有助于预测ESCC患者的OS。